Folashade Otegbeye Profile
Folashade Otegbeye

@DrShadeO

Followers
106
Following
171
Media
5
Statuses
78

Joined October 2021
Don't wanna be here? Send us removal request.
@DrShadeO
Folashade Otegbeye
3 years
My first bench to bedside experience! #NKcells @DrShadeO @paolocaimiMD @DrMarcosdelima @NK_papers.
@ASTCT
ASTCT
3 years
The administration of allogeneic natural killer (NK) cells following a lymphodepleting chemotherapy regimen is emerging as a well-tolerated therapeutic approach in the management of various malignancies. Read more of @DrShadeO article now:
Tweet media one
3
4
24
@DrShadeO
Folashade Otegbeye
5 days
RT @fredhutch: People with darker skin have more melanin, which can act like a “natural sunscreen,” but if you have darker skin, you can st….
0
1
0
@DrShadeO
Folashade Otegbeye
4 months
RT @binaytara: Access to cellular therapy remains a challenge for many communities. Dr. Folashade Otegbeye's talk and the panel discussion….
0
2
0
@DrShadeO
Folashade Otegbeye
6 months
RT @ASTCT: Congratulations to @sghmd, the 2025 recipient of the Lukas D. Wartman GVHD Achievement Award. #Tandem25
Tweet media one
0
4
0
@DrShadeO
Folashade Otegbeye
6 months
RT @ASTCT: Session chair Jennifer Adair of @fredhutch kicks off today’s opening plenary on gene therapy at #Tandem25. .
0
3
0
@DrShadeO
Folashade Otegbeye
6 months
RT @fredhutch: Meet the next generation of hematology and oncology leaders! The Fred Hutch/UW Hematology-Oncology Fellows are at #Tandem25….
0
3
0
@DrShadeO
Folashade Otegbeye
6 months
0
1
1
@DrShadeO
Folashade Otegbeye
6 months
Congratulations @masumi_ueda on a spectacular #Tandem25. In addition to her clinical trial report in the best abstracts plenary, she mentored medical students on two LTFU post-transplant clonal evolution studies also featured at the meeting. #NextGen mentor.
@fredhutch
Fred Hutch Cancer Center
6 months
Fred Hutch at #Tandem25: @masumi_ueda to present results of a novel drug regimen that shows great promise in preventing #cGVHD after transplant in people who received nonmyeloablative or reduced-intensity conditioning to treat a blood cancer.
Tweet media one
2
2
11
@DrShadeO
Folashade Otegbeye
6 months
Congratulations to two phenomenal clinicians who have excelled at leadership, mentorship and advocacy in the transplant and cell therapy field globally. @DrMarcosdelima your inspired and selfless service remains instructive for me, your lifelong mentee. 💐.
@ASTCT
ASTCT
6 months
Congratulations to ASTCT Public Service Award recipients Mary E. Flowers, MD, of @fredhutch and Marcos de Lima, MD, of @OhioState. #Tandem25
Tweet media one
2
3
15
@DrShadeO
Folashade Otegbeye
6 months
RT @ASTCT: Congratulations to ASTCT Public Service Award recipients Mary E. Flowers, MD, of @fredhutch and Marcos de Lima, MD, of @OhioStat….
0
7
0
@DrShadeO
Folashade Otegbeye
6 months
RT @ASTCT: Upcoming best abstract presentation at #Tandem25: Masumi Ueda Oshima, MD, will present the results of a phase II study on a comb….
0
2
0
@DrShadeO
Folashade Otegbeye
7 months
Congratulations @ekimblepl on the @ASTCT New Investigator Award! Excited to see new approaches to CAR T cell therapy in AML. @fredhutch
Tweet media one
1
7
24
@DrShadeO
Folashade Otegbeye
7 months
RT @fredhutch: Substituting cyclophosphamide for a standard post-transplant immunosuppressant is a “gamechanger" for cGVHD, says Fred Hutch….
Tweet card summary image
fredhutch.org
A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in preventing moderate to severe cGVHD after transplant in people who received...
0
2
0
@DrShadeO
Folashade Otegbeye
7 months
RT @fredhutch: Substituting cyclophosphamide for a standard post-transplant immunosuppressant is a “gamechanger" for cGVHD, says Fred Hutch….
Tweet card summary image
fredhutch.org
A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in preventing moderate to severe cGVHD after transplant in people who received...
0
4
0
@DrShadeO
Folashade Otegbeye
8 months
RT @fredhutch: "The fact that there wasn’t a major difference can offer some comfort to physicians and patients by showing that [allogeneic….
Tweet card summary image
fredhutch.org
After an allogeneic stem cell transplant, a recipient’s body faces a daunting task: rebuilding the person’s blood-forming and immune systems from the ground up from a relatively small number of...
0
3
0
@DrShadeO
Folashade Otegbeye
10 months
RT @fredhutch: Applications for the 7th Annual Dr. Eddie Méndez Award is now open! This award recognizes outstanding and diverse #postdocs….
0
7
0
@DrShadeO
Folashade Otegbeye
1 year
RT @TheCancerLetter: Gary Schwartz: “Dr. [Nathan] Berger’s YES summer program has profoundly impacted the education of students from our un….
Tweet card summary image
cancerletter.com
Nathan Berger, professor of medicine, biochemistry, oncology, and genetics; the Hanna-Payne Professor of Experimental Medicine; the director of the Center for Science, Health, and Society; and a...
0
2
0
@DrShadeO
Folashade Otegbeye
1 year
RT @TheCancerLetter: "[Nathan Berger's] contributions to oncology have been immense, marked by groundbreaking research, compassionate patie….
0
4
0
@DrShadeO
Folashade Otegbeye
1 year
Email ofad@fredhutch.org or visit the Fred Hutch Faculty Affairs and Diversity website to learn more about the Eddie Mendez Scholar Award, President’s Postdoctoral Fellowship Program and other efforts to promote a diverse, inclusive cancer research faculty.
0
0
2
@DrShadeO
Folashade Otegbeye
1 year
We were honored to represent @fredhutch and @seattlechildren, sponsors of this exceptionally curated conference. Discussing our experiences, training and career opportunities at Fred Hutch and Seattle Children’s was a highlight for me, @myron_evansPhD, and Dr. Vida Henderson.
@BlackinCancer
BlackinCancer
1 year
A heartfelt thank you to our incredible sponsors for supporting the Black In Cancer Conference. Your contributions are advancing cancer research and building a strong community. Together, we lift as we climb! #bicconf24
1
3
9
@DrShadeO
Folashade Otegbeye
1 year
RT @romeerizwan: Had a wonderful time visiting and presenting some of our early preclinical/clinical data ⁦@fredhutch⁩ today. #romeelab #NK….
0
3
0